Targeted pill trial for aggressive pancreatic cancer ends early
Disease control
Terminated
This study tested whether a daily pill called niraparib could help control advanced pancreatic cancer that had spread and had specific genetic changes. The trial was designed for people who hadn't yet received chemotherapy for their metastatic cancer and had mutations in certain …
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC